advanced search
Marylyn Rigby
Vice-President, Marketing & Investor Relations

Is this your profile?

About

Marylyn Rigby was the Director of Marketing & Investor Relations at SteadyMed Therapeutics, and then at United Therapeutics, after it acquired SteadyMed in 2018, until 2020.

Contributions

WEARABLES
PRODUCT SHOWCASE: STEADYMED THERAPEUTICS’ PATCHPUMP®
SteadyMed leverages its PatchPump® platform to develop its own therapeutic portfolio and partners to optimise the delivery of high volume (greater than 2 mL), high-value, small-molecule or biologic drugs.

More contributions

WEARABLES
PATCHPUMP: EXPANDING THE LIMITS OF PARENTERAL ADMINISTRATION
Marylyn Rigby introduces the company’s PatchPump device, its design, mechanism of action, steps of use and current status of clinical development.
Top